Industries > Pharma > Global Women’s Healthcare Market Forecast 2017-2027

Global Women’s Healthcare Market Forecast 2017-2027

Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome

PUBLISHED: 14 July 2017
PAGES: 154
PRODUCT CODE: PHA0212

Clear
WOOCS 2.2.1
SKU: PHA0212 Categories: , , ,

The revenue of the women’s healthcare market in 2016 is estimated at $31.1bn and is expected to grow at a CAGR of 3.8% in the first half of the forecast period. Among various segments in the Women’s Healthcare market, the Postmenopausal Osteoporosis segment dominated the Global Women’s Healthcare market with a share of 36.99% in 2016.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 96 charts – all unavailable elsewhere.

The 154-page report provides clear detailed insight into the women’s healthcare market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Women’s Healthcare market forecasts from 2017-2027

• This report also breaks down the revenue forecast and SWOT Analysis for the main submarkets:
• Postmenopausal Osteoporosis
• Hormonal Contraceptives
• Infertility
• Endometriosis
• Polycystic Ovary Syndrome

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• The US and Latin America
• Japan
• The UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Rest of the World

Global Women’s Healthcare Market Forecast 2017-2027

• This report provides discussion on pipeline products in various stages of clinical trials and regulatory approval

• This report also discusses the drivers, challenges and trends that affect the global women’s healthcare market

• Our study discusses the selected leading companies that are the major players in the global women’s healthcare market
• Bayer
• Eli Lilly
• Merck & Co.
• Pfizer
• Sanofi
• Amgen
• Novo Nordisk
• AbbVie
• Bristol-Myers Squibb (BMS)

Visiongain’s study is intended for anyone requiring commercial analyses for the women’s healthcare market. You find data, trends and predictions.

Buy our report today Global Women’s Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Women’s Healthcare Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Women’s Healthcare Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories